$13.525
-0.385[-2.77%]
Last update: 11:45AM Get Real Time Here
TG Therapeutics
(NASDAQ:TGTX)TG Therapeutics Stock (NASDAQ:TGTX), Earnings Estimates, EPS, and Revenue
TG Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$54.6M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$233.7M
Analyze the earnings history of TG Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | AM | TGTX | Q1 | -$0.28 | -$0.04 | — | — | $7.80M | $54.58M | — | — | Get Alert |
| 02/28/2024 | AM | TGTX | Q4 | -$0.39 | -$0.10 | -$0.09 | 10.00% | $80.00K | $40.06M | $43.97M | 9.76% | Get Alert |
| 11/01/2023 | AM | TGTX | Q3 | -$0.26 | $0.12 | $0.73 | 508.33% | $94.00K | $46.56M | $165.81M | 256.13% | Get Alert |
| 08/01/2023 | AM | TGTX | Q2 | -$0.30 | -$0.25 | -$0.34 | -36.00% | $594.00K | $17.45M | $16.07M | -7.89% | Get Alert |
| 05/01/2023 | AM | TGTX | Q1 | -$0.51 | -$0.37 | -$0.28 | 24.32% | $2.02M | $3.38M | $7.80M | 130.86% | Get Alert |
| 02/28/2023 | AM | TGTX | Q4 | -$0.70 | -$0.26 | -$0.39 | -50.00% | $2.32M | — | $80.00K | — | Get Alert |
| 11/10/2022 | AM | TGTX | Q3 | -$0.65 | -$0.34 | -$0.26 | 23.53% | $2.03M | — | $94.00K | — | Get Alert |
| 08/08/2022 | AM | TGTX | Q2 | -$0.59 | -$0.51 | -$0.30 | 41.18% | $1.54M | $200.00K | $594.00K | 197.00% | Get Alert |
| 05/10/2022 | AM | TGTX | Q1 | -$0.69 | — | -$0.51 | — | $793.00K | — | $2.02M | — | Get Alert |
| 03/01/2022 | AM | TGTX | Q4 | -$0.71 | -$0.63 | -$0.70 | -11.11% | $38.00K | $6.74M | $2.32M | -65.56% | Get Alert |
| 11/04/2021 | AM | TGTX | Q3 | -$0.73 | -$0.56 | -$0.65 | -16.07% | $38.00K | $2.97M | $2.03M | -31.65% | Get Alert |
| 08/02/2021 | AM | TGTX | Q2 | -$0.47 | -$0.50 | -$0.59 | -18.00% | $38.00K | — | $1.54M | — | Get Alert |
| 05/10/2021 | AM | TGTX | Q1 | -$0.48 | -$0.49 | -$0.69 | -40.82% | $38.00K | $650.00K | $793.00K | 22.00% | Get Alert |
| 03/02/2021 | AM | TGTX | Q4 | -$0.44 | -$0.58 | -$0.71 | -22.41% | $38.00K | $38.00K | $38.00K | 0.00% | Get Alert |
| 11/09/2020 | PM | TGTX | Q3 | -$0.69 | — | -$0.73 | — | $38.00K | — | $38.00K | — | Get Alert |
| 08/10/2020 | AM | TGTX | Q2 | -$0.42 | -$0.34 | -$0.47 | -38.24% | $38.00K | — | $38.00K | — | Get Alert |
| 05/11/2020 | PM | TGTX | Q1 | -$0.43 | — | -$0.48 | — | $38.00K | — | $38.00K | — | Get Alert |
| 03/03/2020 | AM | TGTX | Q4 | -$0.68 | -$0.46 | -$0.44 | 4.35% | $38.00K | — | $38.00K | — | Get Alert |
| 11/12/2019 | AM | TGTX | Q3 | -$0.43 | -$0.34 | -$0.69 | -102.94% | $38.00K | $30.00K | $38.00K | 26.67% | Get Alert |
FAQ
When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?
TG Therapeutics (TGTX) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
What were the latest earnings per share (EPS) for TG Therapeutics (NASDAQ:TGTX)?
The Actual EPS was $-0.09, which beat the estimate of $-0.10.
What were TG Therapeutics’s (NASDAQ:TGTX) revenues?
The Actual Revenue was $44M, which beat the estimate of $40.1M.
Browse earnings estimates, EPS, and revenue on all stocks.